# Tariffs’ Impact On Some Cannabis Businesses May Erase Any Benefits They See From 280E … > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/tariffs-impact-on-some-cannabis-businesses-may-erase-any-benefits-they-see-from-280e/ > **Published:** 2026-05-21T19:16:40-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T17:00:14-04:00 > **Clinical Summary:** How tariffs could offset cannabis 280E tax relief and affect patient access and pricing in the rescheduling era. --- ✦ New CED Clinical Relevance #35 [Clinical Context](https://cedclinic.com/cannabis-hyperemesis-syndrome-treatment-insights-2026/) Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. PolicyIndustryResearchHempTHCCBDSafety Dr. Caplan’s Take “The real clinical problem we’re facing isn’t tariff policy or tax code—it’s that when small cannabis producers get squeezed by competing cost pressures, they cut corners on testing, quality control, and worker safety, and those shortcuts end up in my patients’ lungs and bloodstreams.” Clinical Perspective The intersection of federal tax policy and [cannabis business economics](https://cedclinic.com/cannabis-industry-wage-crisis-minimum-wage-impact-2026/) presents a nuanced challenge for clinicians advocating for patients in states where cannabis is legal. While the potential removal or modification of Internal Revenue Code Section 280E (which prohibits cannabis businesses from deducting ordinary business expenses) could theoretically improve product affordability and accessibility, concurrent tariff policies may offset these gains by increasing operational costs for cultivators and retailers. Healthcare providers should recognize that cannabis pricing and availability in their communities are shaped by complex fiscal policies beyond clinical considerations, and that patients’ out-of-pocket costs may remain elevated regardless of tax or tariff changes. When counseling patients about [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) for symptom management, clinicians should remain attuned to cost barriers that may influence adherence or drive patients toward unregulated products, while advocating for transparent information about how regulatory and fiscal environments affect the legal cannabis market they’re recommending. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Tariffs%27%20Impact%20On%20Some%20Cannabis%20Businesses%20May%20Erase%20Any%20Benefits%20They%20See%20From%20280E%20...%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D56018)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D56018)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Tariffs%27%20Impact%20On%20Some%20Cannabis%20Businesses%20May%20Erase%20Any%20Benefits%20They%20See%20From%20280E%20...%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D56018)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) 📰 Source: [https://www.marijuanamoment.net/tariffs-impact-on-some-cannabis-businesses-may-erase-any-benefits-they-see-from-280e-tax-relief-under-rescheduling-op-ed/](https://www.marijuanamoment.net/tariffs-impact-on-some-cannabis-businesses-may-erase-any-benefits-they-see-from-280e-tax-relief-under-rescheduling-op-ed/) Further Reading CED Clinic Blog[Histamine Brain Pathways and Psychiatric Disorders](https://cedclinic.com/histamine-brain-pathways-psychiatric-disorders/) Cannabis Policy WireCED Regulatory Digest, Since Last Digest, 1 items Evidence Watch[Cannabinoids in Mental Health Treatment: A Systematic Review and Meta-Analysis](https://cedclinic.com/cannabinoids-mental-health-substance-use-disorders-review/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).